PaxMedica, Inc. Common Stock (PXMD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | 16.14 Million | 10.6 Million | 7.19 Million | 5.56 Million | 598.6 Thousand |
| Selling, General and Administrative Expenses | 12.23 Million | 8.81 Million | 4.97 Million | 4.62 Million | 114.49 Thousand |
| Research and Development Expenses | 3.91 Million | 1.78 Million | 2.22 Million | 936.77 Thousand | 484.11 Thousand |
| Other Expenses | - | -5.51 Million | 173.35 Thousand | -53.54 Thousand | - |
| Cost and Expenses | 16.14 Million | 10.6 Million | 7.19 Million | 5.56 Million | 598.6 Thousand |
| Operating Income | -16.14 Million | -10.6 Million | -7.19 Million | -5.56 Million | -598.6 Thousand |
| Interest Expense | 9165.00 | 5237.00 | 2.8 Million | 609.45 Thousand | - |
| Income Tax Expense | -167.89 Thousand | 4.19 Million | 2.8 Million | 662.99 Thousand | -171.86 Thousand |
| Earnings before Tax | -18.28 Million | -14.8 Million | -10.22 Million | -7.82 Million | -598.6 Thousand |
| Net Income | -18.28 Million | -14.8 Million | -13.03 Million | -8.48 Million | -598.6 Thousand |
| Earnings Per Share Basic | -11.00 | -28.79 | -18.81 | -12.25 | -0.06 |
| Earnings Per Share Diluted | -11.00 | -28.79 | -18.81 | -12.25 | -0.06 |
| Weighted Average Shares Outstanding | 1.66 Million | 514.21 Thousand | 692.91 Thousand | 692.91 Thousand | 10.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.66 Million | 514.21 Thousand | 692.91 Thousand | 692.91 Thousand | 10.01 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -16.14 Million | -10.6 Million | -7.19 Million | -5.61 Million | -598.6 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 2.99 Million | 3.69 Million | 16.14 Million | 4.38 Million | 4.36 Million | 3.35 Million |
| Selling, General and Administrative Expenses | 1.48 Million | 3.29 Million | - | 3.22 Million | 2.42 Million | 2.76 Million |
| Research and Development Expenses | 1.5 Million | 392.81 Thousand | - | 1.16 Million | 1.93 Million | 589.02 Thousand |
| Other Expenses | 729.00 | -3022.00 | - | -1.88 Million | -325.98 Thousand | -124.42 Thousand |
| Cost and Expenses | 2.99 Million | 3.69 Million | 16.14 Million | 4.38 Million | 4.36 Million | 3.35 Million |
| Operating Income | -2.99 Million | -3.69 Million | -16.14 Million | -4.38 Million | -4.36 Million | -3.35 Million |
| Interest Expense | - | - | 9165.00 | -9.17 Million | 1309.00 | 3928.00 |
| Income Tax Expense | - | -46.29 Thousand | -167.89 Thousand | 193.76 Thousand | 1309.00 | 3928.00 |
| Earnings before Tax | -2.99 Million | -3.69 Million | -18.28 Million | -5.92 Million | -5.04 Million | -3.48 Million |
| Net Income | -2.99 Million | -3.69 Million | -18.28 Million | -5.92 Million | -5.04 Million | -3.48 Million |
| Earnings Per Share Basic | -0.39 | -0.50 | - | -0.80 | -5.20 | -4.05 |
| Earnings Per Share Diluted | -0.39 | -0.50 | - | -0.80 | -5.20 | -4.05 |
| Weighted Average Shares Outstanding | 7.65 Million | 7.41 Million | 1.66 Million | 7.4 Million | 971.73 Thousand | 860.71 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 7.65 Million | 7.41 Million | 1.66 Million | 7.4 Million | 971.73 Thousand | 860.71 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -2.99 Million | -3.69 Million | - | -4.38 Million | -4.69 Million | -3.48 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
VUK
CIHHF
002765
RKLIF
ICNB
TWL